KALDENN Trademark

Trademark Overview


On Tuesday, May 14, 2024, a trademark application was filed for KALDENN with the United States Patent and Trademark Office. The USPTO has given the KALDENN trademark a serial number of 79403077. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Tuesday, June 3, 2025. This trademark is owned by NAOGEN PHARMA. The KALDENN trademark is filed in the Chemical Products, Pharmaceutical Products, and Medical Instrument Products categories with the following description:

Radiopharmaceutical products, namely, radioactive substances for use in nuclear medicine; radioactive products for medical use, namely, radioactive pharmaceutical preparations for use in vivo diagnostic or therapeutic use; radioactive substances for medical use; isotopes for medical use; radiopharmaceutical preparations for medical use made from radiopharmaceutical generators, namely, for the detection and treatment of cancers, coronary diseases, coronary artery diseases, heart diseases and myocardial ischaemia; diagnostic radiopharmaceutical preparations; reagents and substances for medical diagnostic purposes; diagnostic biomarking reagents for medical use; contrast products being media for use with medical imaging equipment; cardiovascular medicines used in myocardial infarction treatment; contrast agents being media for use with molecular imaging equipment for medical use

Chemical substances, chemical materials and chemical products for use in medicine production, namely, chemical additives and active chemical ingredients for use in the manufacture of radiopharmaceutical preparations and pharmaceuticals for detecting and treating coronary diseases and coronary artery diseases; chemical substances, chemical preparations and chemical products for use in radiopharmaceutical product manufacture, namely, chemical additives and active chemical ingredients for use in the manufacture of radiopharmaceutical preparations and pharmaceuticals for detecting and treating myocardial ischaemia; active chemical ingredients for use in manufacture of radiopharmaceutical preparations against cancer; diagnostic preparations for scientific use or for research; diagnostic reagents for scientific use or for research; radioactive preparations for laboratory use for scientific purposes; contrast agents for molecular imaging other than for medical use; rubidium; strontium

Radiopharmaceutical generators for medical use being medical generators specially adapted for medical, diagnostic and therapeutic purposes, namely for use in the production and transportation of nuclear medicines, radioactive substances for medical purposes, radiopharmaceutical products and radiopharmaceutical medicines; radioactive and radiopharmaceutical product generators for medical use being medical generators specially adapted for medical nuclear medicine purposes, namely for use in the production and transportation of nuclear medicines, radioactive substances for medical purposes, radiopharmaceutical products and radiopharmaceutical medicines; rubidium-82 generators for medical use being medical generators specially adapted for medical, diagnostic and therapeutic purposes, namely for use in the production and transportation of nuclear medicines, radioactive substances for medical purposes, radiopharmaceutical products and radiopharmaceutical medicines; medication injectors for m...
kaldenn

General Information


Serial Number79403077
Word MarkKALDENN
Filing DateTuesday, May 14, 2024
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateTuesday, June 3, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 24, 2025

Trademark Statements


Goods and ServicesRadiopharmaceutical products, namely, radioactive substances for use in nuclear medicine; radioactive products for medical use, namely, radioactive pharmaceutical preparations for use in vivo diagnostic or therapeutic use; radioactive substances for medical use; isotopes for medical use; radiopharmaceutical preparations for medical use made from radiopharmaceutical generators, namely, for the detection and treatment of cancers, coronary diseases, coronary artery diseases, heart diseases and myocardial ischaemia; diagnostic radiopharmaceutical preparations; reagents and substances for medical diagnostic purposes; diagnostic biomarking reagents for medical use; contrast products being media for use with medical imaging equipment; cardiovascular medicines used in myocardial infarction treatment; contrast agents being media for use with molecular imaging equipment for medical use
Goods and ServicesChemical substances, chemical materials and chemical products for use in medicine production, namely, chemical additives and active chemical ingredients for use in the manufacture of radiopharmaceutical preparations and pharmaceuticals for detecting and treating coronary diseases and coronary artery diseases; chemical substances, chemical preparations and chemical products for use in radiopharmaceutical product manufacture, namely, chemical additives and active chemical ingredients for use in the manufacture of radiopharmaceutical preparations and pharmaceuticals for detecting and treating myocardial ischaemia; active chemical ingredients for use in manufacture of radiopharmaceutical preparations against cancer; diagnostic preparations for scientific use or for research; diagnostic reagents for scientific use or for research; radioactive preparations for laboratory use for scientific purposes; contrast agents for molecular imaging other than for medical use; rubidium; strontium
Goods and ServicesRadiopharmaceutical generators for medical use being medical generators specially adapted for medical, diagnostic and therapeutic purposes, namely for use in the production and transportation of nuclear medicines, radioactive substances for medical purposes, radiopharmaceutical products and radiopharmaceutical medicines; radioactive and radiopharmaceutical product generators for medical use being medical generators specially adapted for medical nuclear medicine purposes, namely for use in the production and transportation of nuclear medicines, radioactive substances for medical purposes, radiopharmaceutical products and radiopharmaceutical medicines; rubidium-82 generators for medical use being medical generators specially adapted for medical, diagnostic and therapeutic purposes, namely for use in the production and transportation of nuclear medicines, radioactive substances for medical purposes, radiopharmaceutical products and radiopharmaceutical medicines; medication injectors for medical use, namely, medical fluid injectors and injection devices for pharmaceuticals and radiopharmaceutical products; radiopharmaceutical medicine injectors being injection devices; radioactive and radiopharmaceutical product injectors for medical use being injection devices for pharmaceuticals, radioactive products and radiopharmaceutical products; automatic injectors being injection devices for administering radiopharmaceutical products; injectors of rubidium-82 to patients for medical use, namely, medical fluid injectors and injection devices for pharmaceuticals, radioactive products and radiopharmaceutical products; magnetic resonance tomography apparatus, namely, magnetic resonance imaging apparatus for medical purposes; medical equipment, namely, computed tomography apparatus; tomographic scanners for nuclear medicine, namely, X-ray CT scanners; medical apparatus for diagnosing suspected heart attacks

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateThursday, August 29, 2024
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, August 29, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, August 29, 2024
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNAOGEN PHARMA
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressFR

Trademark Events


Event DateEvent Description
Thursday, August 29, 2024SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, September 3, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 3, 2024APPLICATION FILING RECEIPT MAILED
Tuesday, November 26, 2024ASSIGNED TO EXAMINER
Thursday, December 12, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, December 12, 2024REFUSAL PROCESSED BY MPU
Wednesday, November 27, 2024NON-FINAL ACTION WRITTEN
Thursday, November 28, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sunday, December 29, 2024REFUSAL PROCESSED BY IB
Thursday, May 15, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 15, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, May 15, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, May 15, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 15, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 15, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, May 15, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, May 15, 2025TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, May 15, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, May 21, 2025APPROVED FOR PUB - PRINCIPAL REGISTER